Fred Walder Joins Fluidigm as Chief Business
Senior Executive from Fortune 500 Company to Lead Business Development and Marketing for
Integrated Fluidic Circuit Inventor
June 29, 2010 08:03 AM Eastern Daylight Time
SOUTH SAN FRANCISCO, Calif.--(EON: Enhanced Online News)--Fluidigm Corporation today announced
Fred Walder has joined the company as its new Chief Business Officer. Walder joins Fluidigm after a long and
celebrated career at a Fortune 500 company, Thermo Fisher Scientific, where he was most recently Senior Vice
President, Customer and Commercial Excellence. Thermo Fisher is a $10+ billion (revenue) leader in the life
For Fluidigm, Walder will lead the company’s business functions to increase awareness and cement opportunities for
Fluidigm integrated fluidic circuit-based technologies. Products based on these technologies bring unique capabilities
to researchers working on single-cell gene expression, high-sample throughput genotyping and automated sample
preparation and target enrichment for users of next generation sequencers.
“Fred brings a new level of business acumen to Fluidigm. His experience and wisdom will help us uncover fresh
opportunities and drive Fluidigm’s growth to new heights,” said Gajus Worthington, president and chief executive
officer of Fluidigm. “We have been seeking a person of unique capabilities to fill this position and just weren’t willing
to compromise on someone who didn’t meet all of our needs. Fred exceeded those requirements and we believe we
have strengthened our team significantly with his addition to Fluidigm.”
Fred Walder, Fluidigm's new Chief Business Officer said, "Fluidigm technology brings amazing new capabilities to
life science fields such as single-cell gene expression and stem cell research. I believe integrated fluidic circuit
technology is the real deal. It provides a significant enabling tool for understanding much more about how cells
Walder’s career began as an Engineering and Scientific Associate at Sandia National laboratories in 1979. A few
years later he joined Nicolet Instrument Corporation where he spent 10 years in a variety of technical and
management positions. In Thermo Fisher, one of the largest companies in the life science industry, Walder held
various senior operating roles including president of several operating divisions. In his most recent position, Walder
served as a corporate officer and Senior Vice President, Customer and Commercial Excellence reporting to Thermo
Fisher’s Chief Executive Officer.
Walder received his Bachelor of Science in Chemistry from the University of Massachusetts. The University
awarded Walder with their Career Achievement Award in 2008. He also completed the Technology Leadership
Program at Stanford University’s Executive Institute, Graduate School of Business.
Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly
improve productivity in life science research. Fluidigm’s IFCs enable the simultaneous performance of thousands of
sophisticated biochemical measurements in extremely minute volumes. These “integrated circuits for biology” are
made possible by miniaturizing and integrating liquid handling components on a single microfluidic device. Fluidigm’s
systems, consisting of instrumentation, software and chips, increase throughput, decrease costs and enhance
sensitivity compared to conventional laboratory systems.
For more information, please visit www.fluidigm.com.
Fluidigm, the Fluidigm logo, BioMark, Access Array, Dynamic Array, Digital Array, FC1, Topaz, and NanoFlex are
trademarks or registered trademarks of Fluidigm Corporation.
Howard High, 650-266-6081 (office)